Free tool
Cell therapy stocks
We cover 86 companies grouped under the Cell therapy theme. The median market value in the group is $57.47M. Across the group, the median move over the past trading day is +0.57%. 40% of the 84 with a 200-day average trade above it. Price change over the past year runs from −73.4% to +88.4% across the middle 80 percent of the group, with a median of −20.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LEGN | Legend Biotech Corporation | $21.30 | +10.53% | −0.98% | −38.44% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.44 | +72.24% | +234.92% | +233.60% |
| MSB.AX | Mesoblast Limited | 2.40 AUD | +16.26% | −13.54% | −3.82% |
| MESO | Mesoblast Limited | $17.19 | +18.06% | −5.34% | +9.42% |
| VCEL | Vericel Corporation | $43.22 | −4.63% | +21.37% | +20.76% |
| BLFS | BioLife Solutions, Inc. | $37.22 | +24.94% | +55.80% | +45.11% |
| VOR | Vor Biopharma Inc. | $24.01 | +23.51% | +106.27% | −41.72% |
| SANA | Sana Biotechnology, Inc. | $4.10 | +25.00% | −2.15% | +22.39% |
| IMMX | Immix Biopharma, Inc. | $14.47 | +66.51% | +166.48% | +589.05% |
| SYNC.L | Syncona Limited | 111.40 GBP | +5.69% | +16.65% | +15.68% |
| CYRX | Cryoport, Inc. | $16.72 | +10.36% | +74.90% | +89.78% |
| ALLO | Allogene Therapeutics, Inc. | $2.17 | +24.00% | +60.74% | +87.07% |
| PROK | ProKidney Corp. | $1.73 | +12.34% | −22.42% | −26.38% |
| AUTL | Autolus Therapeutics plc | $2.44 | +67.12% | +30.48% | +52.50% |
| ARTV | Artiva Biotherapeutics, Inc. | $11.77 | +14.05% | +178.25% | +317.38% |
| KYTX | Kyverna Therapeutics, Inc. | $8.84 | +11.62% | +0.80% | +132.02% |
| CABA | Cabaletta Bio, Inc. | $3.22 | +18.38% | +45.70% | +102.52% |
| 0JDK.L | Iovance Biotherapeutics, Inc. | $8.36 | +1.91% | +222.92% | +248.46% |
| 4592.T | SanBio Company Limited | 1,024.00 JPY | +10.58% | −37.45% | −55.90% |
| CAPR | Capricor Therapeutics, Inc. | $8.29 | +18.43% | −70.72% | +25.61% |
| 005690.KS | Pharmicell Co., Ltd. | 10,830.00 KRW | +10.85% | −24.90% | +1.56% |
| 0HX7.L | Adicet Bio, Inc. | $9.03 | +0.56% | +5.00% | −24.75% |
| IPSC | Century Therapeutics, Inc. | $2.17 | +3.83% | +118.09% | +324.66% |
| LYEL | Lyell Immunopharma, Inc. | $15.49 | +19.52% | −46.55% | +41.20% |
| ALCLS.PA | Cellectis S.A. | 2.76 EUR | +9.63% | −34.61% | +19.05% |
| CLLS | Cellectis S.A. | $3.42 | +18.34% | −28.75% | +27.14% |
| 219A.T | HEARTSEED INC | 2,365.00 JPY | +36.94% | +31.02% | −32.33% |
| FATE | Fate Therapeutics, Inc. Common Stock | $2.55 | +4.94% | +157.58% | +133.94% |
| RNAC | Cartesian Therapeutics, Inc. | $10.38 | +33.25% | +53.55% | −7.73% |
| 4894.T | Cuorips Inc. | 5,670.00 JPY | +37.29% | −8.84% | −19.00% |
| LCTX | Lineage Cell Therapeutics, Inc. | $1.13 | +9.71% | −31.10% | −3.42% |
| 4593.T | Healios K.K. | 283.00 JPY | +25.22% | +0.71% | −40.92% |
| 7774.T | Japan Tissue Engineering Co., Ltd. | 875.00 JPY | +41.82% | +49.57% | +79.30% |
| NKTX | Nkarta, Inc. | $2.71 | +19.91% | +44.92% | +23.18% |
| 504A.T | Innovacell Inc. | 555.00 JPY | +17.34% | −47.14% | −47.14% |
| OCC.AX | Orthocell Limited | 0.78 AUD | +9.86% | −30.36% | −35.00% |
| MXCT | MaxCyte, Inc. | $1.35 | +32.35% | −12.90% | −2.88% |
| 0HIY.L | Atara Biotherapeutics, Inc. | $9.92 | +1.60% | −44.67% | −20.36% |
| ATRA | Atara Biotherapeutics, Inc. | $9.84 | +27.63% | −44.63% | −19.61% |
| ACET | Adicet Bio, Inc. | $9.00 | +11.66% | +2.04% | −20.89% |
| INKT | MiNK Therapeutics, Inc. | $11.38 | +7.46% | +2.34% | −21.89% |
| V3V.DE | FamiCord AG | 2.85 EUR | −3.06% | −52.89% | −60.69% |
| 7776.T | CellSeed Inc. | 234.00 JPY | +13.59% | −16.13% | −47.42% |
| 4896.T | K Pharma,Inc. | 773.00 JPY | +4.46% | +15.37% | +15.89% |
| 4584.T | Kidswell Bio Corporation | 180.00 JPY | +28.57% | −15.09% | −24.37% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 580.00 GBP | −17.08% | +2.11% | +81.25% |
| ALA.AX | Arovella Therapeutics Limited | 0.06 AUD | −3.13% | −33.33% | −26.19% |
| ALPS | Alps Group Inc | $0.31 | −32.74% | −65.44% | −87.70% |
| TCRX | TScan Therapeutics, Inc. | $0.79 | +3.35% | −22.19% | −58.23% |
| 7096.T | StemCell Institute Inc. | 772.00 JPY | +6.63% | −2.03% | −21.54% |
| TVGN | Tevogen Inc. | $6.97 | +25.13% | −61.70% | −84.85% |
| 2370.T | MEDINET Co., Ltd. | 25.00 JPY | +4.17% | −13.79% | −34.21% |
| 3750.T | ADR Biomedical Holdings Inc. | 773.00 JPY | −0.64% | −9.48% | −15.61% |
| 4880.T | CellSource Co., Ltd. | 347.00 JPY | +10.51% | −13.25% | −41.78% |
| DTSQ | DT Cloud Star Acquisition Corporation | $11.33 | −0.18% | +4.72% | +8.42% |
| 4893.T | Noile-Immune Biotech Inc. | 148.00 JPY | +3.50% | +10.45% | −17.32% |
| PTG.WA | Poltreg S.A. | 25.20 PLN | +14.03% | −1.18% | −16.00% |
| 4892.T | Cyfuse Biomedical K.K. | 571.00 JPY | +10.66% | −5.93% | −9.22% |
| CCEL | Cryo-Cell International, Inc. | $4.30 | +30.30% | +25.36% | −0.92% |
| ESLA | Estrella Immunopharma, Inc. | $0.73 | −5.48% | −47.30% | −24.41% |
| SVA.TO | Sernova Biotherapeutics Inc | 0.11 CAD | −8.33% | −15.38% | −38.89% |
| PSH0.DE | Sernova Biotherapeutics Inc | 0.06 EUR | −9.73% | −26.71% | −46.78% |
| 0NLV.L | FamiCord AG | 2.78 EUR | −1.55% | −53.28% | −61.12% |
| LGVN | Longeveron Inc. | $0.68 | +11.29% | +14.67% | −12.71% |
| 311A.T | NPT Co Ltd | 680.00 JPY | 0.00% | −2.86% | −43.33% |
| NCEL | NewcelX Ltd. | $3.48 | −3.33% | +66.51% | −85.80% |
| PLUR | Pluri Inc. | $1.56 | −4.88% | −47.83% | −71.43% |
| BCDA | BioCardia, Inc. | $1.13 | +39.51% | −11.02% | −42.05% |
| SNTI | Senti Biosciences Holdings, Inc. | $0.39 | +4.52% | −64.46% | −75.42% |
| F98.F | CytoMed Therapeutics Limited | 0.75 EUR | −3.23% | −75.81% | −54.82% |
| INAB | IN8bio, Inc. | $1.17 | −1.68% | −52.44% | −46.58% |
| GDTC | CytoMed Therapeutics Limited | $0.94 | +3.89% | −32.73% | −52.59% |
| FBLG | FibroBiologics, Inc. | $1.40 | +123.29% | −70.83% | −88.54% |
| CMB.AX | Cambium Bio Limited | 0.42 AUD | −2.33% | −9.68% | 0.00% |
| CELZ | Creative Medical Technology Holdings, Inc. | $1.24 | +56.31% | −37.06% | −61.19% |
| 1AD.AX | AdAlta Limited | 0.00 AUD | −12.50% | −12.50% | −12.50% |
| ERNA | Ernexa Therapeutics Inc. | $4.93 | +25.64% | −83.02% | −86.22% |
| PMCB | PharmaCyte Biotech, Inc. | $0.53 | −10.26% | −28.86% | −48.78% |
| BRTX | BioRestorative Therapies, Inc. | $0.22 | −19.68% | −81.76% | −85.26% |
| 0QFK.L | Celyad Oncology SA | 0.26 EUR | −7.09% | +46.29% | −16.07% |
| MBIO | Mustang Bio, Inc. | $0.55 | −1.43% | −48.41% | −64.16% |
| BSFA.L | BSF Enterprise Plc | 1.25 GBP | +56.25% | −34.21% | −44.44% |
| CYP.AX | Cynata Therapeutics Limited | 0.01 AUD | −8.33% | −96.90% | −94.88% |
| CHM.AX | Chimeric Therapeutics Limited | 0.01 AUD | −65.79% | −93.50% | −95.67% |
| CRBU | Caribou Biosciences, Inc. | $1.76 | +10.69% | +10.69% | −6.38% |
| DTSQU | DT Cloud Star Acquisition Corporation | $11.49 | 0.00% | +4.95% | +9.95% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.